Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.45 |
| ▸ | KDM6B | O15054 | 1/20 | 0.45 |
| ▸ | KDM5C | P41229 | 1/20 | 0.45 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.45 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.41 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.41 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopropane SCHEMBL10940609 | 1.00 | LMNA (0.55) | LMNACYP1A2MGAMGAASI | |
| SCHEMBL363334 | 0.93 | MGAM (0.55) | LMNACYP1A2MGAMGAASI | |
| SCHEMBL262913 | 0.93 | MGAM (0.55) | LMNACYP1A2MGAMGAASI | |
| Succinic Acid Diethyl Ester SCHEMBL27830938 | 0.93 | MGAM (0.55) | LMNACYP1A2MGAMGAASI | |
| Succinic Acid Diethyl Ester SCHEMBL27966388 | 0.93 | MGAM (0.55) | LMNACYP1A2MGAMGAASI | |
| Methyl Alcohol SCHEMBL2707570 | 0.91 | MGAM (0.52) | LMNACYP1A2MGAMGAASI | |
| Water SCHEMBL1110192 | 0.91 | MGAM (0.52) | LMNACYP1A2MGAMGAASI | |
| SCHEMBL818402 | 0.91 | MGAM (0.52) | LMNACYP1A2MGAMGAASI | |
| Hydrochloric Acid SCHEMBL1006465 | 0.91 | MGAM (0.52) | LMNACYP1A2MGAMGAASI | |
| Methyl Alcohol SCHEMBL6759312 | 0.91 | MGAM (0.52) | LMNACYP1A2MGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108627582-A | A kind of Fructus Aristolochiae Kwangsiensis drug for analgesic | 贵州景诚制药有限公司 | 2018-10-09 | — | — | CN | claimed |
| US-10667993-B2 | Polymerizable compositions based on thermally cleavable compounds | IVOCLAR VIVADENT AG (LI) | 2020-06-02 | — | — | US | disclosed |
| CN-108627582-A | A kind of Fructus Aristolochiae Kwangsiensis drug for analgesic | 贵州景诚制药有限公司 | 2018-10-09 | — | — | CN | disclosed |
| US-20180200155-A1 | Polymerizable Compositions Based On Thermally Cleavable Compounds | IVOCLAR VIVADENT AG (LI) | 2018-07-19 | — | — | US | disclosed |
| EP-2906539-B1 | INHIBITORS OF VIRAL REPLICATION, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES | HIVIH (FR) | 2017-06-21 | — | — | EP | disclosed |
| US-9475802-B2 | Inhibitors of viral replication, their process of preparation and their therapeutical uses | LABORATOIRE BIODIM (FR) | 2016-10-25 | — | — | US | disclosed |
| EP-2886531-B1 | Aspartic acid derivatives | MERCK PATENT GMBH (DE) | 2016-06-08 | — | — | EP | disclosed |
| US-20150274718-A1 | Inhibitors of Viral Replication, Their Process of Preparation and Their Therapeutical Uses | LABORATOIRE BIODIM (FR) | 2015-10-01 | — | — | US | disclosed |
| EP-2906539-A1 | INHIBITORS OF VIRAL REPLICATION, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES | LABORATOIRE BIODIM (FR) | 2015-08-19 | — | — | EP | disclosed |
| EP-2886531-A1 | Aspartic acid derivatives | Merck Patent GmbH (DE) | 2015-06-24 | — | — | EP | disclosed |
| US-4180672-A | 2-Organothio-2-cyclopentenones, organothio-cyclopentanes derived therefrom | TEIJIN LIMITED (JP) | 1979-12-25 | — | — | US | disclosed |
| US-4179575-A | CYCLOPROPANECARBOXYLIC ACIDS, PESTICIDES | ROUSSEL UCLAF (FR) | 1979-12-18 | — | — | US | disclosed |
| US-4178461-A | BRONCHODILATORS, GASTRIC ACID SECRETION INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1979-12-11 | — | — | US | disclosed |
| US-4054604-A | MICROBIOCIDES, HYPOTENSIVE AGENTS | AMERICAN CYANAMID COMPANY (US) | 1977-10-18 | — | — | US | disclosed |
| US-4045577-A | 15-PROPIONYLOXY-9-OXO-5,13 PROSTADIENOIC ACID, ANTIHYPERTENSIVE AGENTS | ALZA CORPORATION (US) | 1977-08-30 | — | — | US | disclosed |
| US-4044043-A | HYPERTENSIVE AGENTS, MICROBIOCIDES | AMERICAN CYANAMID COMPANY (US) | 1977-08-23 | — | — | US | disclosed |
| US-4028396-A | BRONCHODILATORS, GASTRIC ACID SECRETION INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1977-06-07 | — | — | US | disclosed |
| US-3994865-A | MELT SPINNING | CIBA-GEIGY CORPORATION (US) | 1976-11-30 | — | — | US | disclosed |
| US-3981868-A | MICROBIOCIDES, HYPOTENSIVE AGENTS | AMERICAN CYANAMID COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
| US-3975413-A | Novel haptenes and antigens | PIERDET ANDRE | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180200155-A1 | Polymerizable Compositions Based On Thermally Cleavable Compounds | CAD, TERB1, MLX | LMNA 157/4885CYP1A2 2458/4885MGAM 2817/4885 |
| US-10667993-B2 | Polymerizable compositions based on thermally cleavable compounds | CAD, TERB1, MLX | LMNA 157/4885CYP1A2 2458/4885MGAM 2817/4885 |
| US-20150274718-A1 | Inhibitors of Viral Replication, Their Process of Preparation and Their Therapeutical Uses | RPL35, EIF2AK2, MAVS | LMNA 1718/4885CYP1A2 2862/4885MGAM 1313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.